- Avicanna (TSX:AVCN), a Canadian cannabis stock, has unveiled the initial product offering on its MyMedi.ca medical cannabis platform launching on Aug. 1
- These include well established brands such as Spinach, Bhang, Pure Sunfarms and Medipharm Labs
- Avicanna is an international biopharmaceutical company focused on cannabinoid-based products for the global medical and pharmaceutical markets
- Avicanna (TSX:AVCN) last traded at $0.305 per share
Avicanna (TSX:AVCN), a Canadian cannabis stock, has unveiled the initial product offering on its MyMedi.ca medical cannabis platform launching on Aug. 1.
Source: Avicanna.
“We are pleased by the level of commitment towards patients that we have seen and the concrete support of this distinct group of Canadian licensed producers that have worked towards the timely launch of the new cannabis care platform, MyMedi.ca. We look forward to continuing to work collaboratively towards the goals of establishing MyMedi.ca as a leading cannabis care platform and towards taking steps to enhance the patient journey,” Aras Azadian, CEO of Avicanna, said in a statement.
The MyMedi platform will offer a diverse portfolio of products, including 35 brands and more than 200 SKUs from Canadian licensed producers.
The platform is providing continuity of care for Medical Cannabis by Shoppers Drug Mart patients following a partnership between Avicanna and Shoppers Drug Mart signed in March.
Avicanna is an international biopharmaceutical company focused on cannabinoid-based products for the global medical and pharmaceutical markets.
Avicanna (TSX:AVCN) last traded at $0.305 per share.
Join the discussion: Find out what everybody’s saying about this stock on the Avicanna Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.